The prognostic value of very low admission LDL-cholesterol levels in ST-segment elevation myocardial infarction compared in statin-pretreated and statin-naive patients undergoing primary percutaneous coronary intervention

International Journal of Cardiology

Volumn 167, Issue 2, 2013, Pages 458-463

  Oduncu, Vecih ^a   Erkol, Ayhan ^a   Kurt, Mustafa ^a   Tanboǧa, Ibrahim Halil ^a   Karabay, Can Yücel ^a   Şengül, Cihan ^a   Bulut, Mustafa ^a   Özveren, Olcay ^a   Fotbolcu, Hakan ^a   Akgün, Taylan ^a   Türkyilmaz, Erdem ^a   Kirma, Cevat ^a  

^a NONE

Author keywords

Cholesterol; Low density lipoprotein; Myocardial infarction; Prognosis; Statins

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; FLUINDOSTATIN; GLYCERYL TRINITRATE; HEPARIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TIROFIBAN;

ADULT; ANEMIA; ANGIOPLASTY; ARTICLE; BLOOD SAMPLING; CARDIOGENIC SHOCK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY FAILURE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

ADULT; AGED; CHOLESTEROL, LDL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84879090963     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.01.009     Document Type: Article

References (26)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
2. J. Shepherd, S.M. Cobbe, and I. Ford Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group N Engl J Med 333 1995 1301 1307
3. S.M. Grundy, J.I. Cleeman, and C.N. Merz Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239
4. K.H. Cho, M.H. Jeong, and Y. Ahn Low-density lipoprotein cholesterol level in patients with acute myocardial infarction having percutaneous coronary intervention (the cholesterol paradox) Am J Cardiol 106 2010 1061 1068
5. M.H. Al-Mallah, H. Hatahet, and J.L. Cavalcante Low admission LDL-cholesterol is associated with increased 3-year all-cause mortality in patients with non ST segment elevation myocardial infarction Cardiol J 16 2009 227 233
6. J.A. de Lemos, and E. Braunwald ST segment resolution as a tool for assessing the efficacy of reperfusion therapy J Am Coll Cardiol 38 2001 1283 1294
7. C.M. Gibson, J.A. de Lemos, and S.A. Murphy Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: A TIMI 14 substudy Circulation 103 2001 2550 2554
8. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo controlled trial Lancet 360 2002 7 22
9. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels N Engl J Med 339 1998 1349 1357
10. Cholesterol Treatment Trialists' (CTT) Collaboration Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170000 participants in 26 randomised trials Lancet 376 2010 1670 1681
11. C.P. Cannon, E. Braunwald, and C.H. McCabe Pravastatin or Atorvastatin Evaluation and Infection Therapy - Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
12. S.D. Wiviott, C.P. Cannon, and D.A. Morrow Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy J Am Coll Cardiol 46 2005 1411 1416
13. P.M. Ridker, N. Rifai, and M. Clearfield Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events N Engl J Med 344 2001 1959 1965
14. J.W. Son, K.K. Koh, and J.Y. Ahn Effects of statin on plaque stability and thrombogenicity in hypercholesterolemic patients with coronary artery disease Int J Cardiol 88 2003 77 82
15. S.P. Jones, Y. Teshima, and M. Akao Simvastatin attenuates oxidant-induced mitochondrial dysfunction in cardiac myocytes Circ Res 93 2003 697 699
16. U. Laufs, V. La Fata, and J. Plutzky Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 1998 1129 1135
17. E.I. Lev, R. Kornowski, and H. Vaknin-Assa Effect of previous treatment with statins on outcome of patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention Am J Cardiol 103 2009 165 169
18. Y. Liu, J. Coresh, and J.A. Eustace Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition JAMA 291 2004 451 459
19. T.B. Horwich, W.R. MacLellan, and G.C. Fonarow Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure J Am Coll Cardiol 43 2004 642 648
20. G. Charach, J. George, and A. Roth Baseline low-density lipoprotein cholesterol levels and outcome in patients with heart failure Am J Cardiol 105 2010 100 104
21. M. Christ, T. Klima, and W. Grimm Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy Eur Heart J 27 2006 691 699
22. V. Oduncu, A.C. Tanalp, and A. Erkol Impact of chronic pre-treatment of statins on the level of systemic inflammation and myocardial perfusion in patients undergoing primary angioplasty Am J Cardiol 107 2011 179 185
23. R.R. Giraldez, R.P. Giugliano, and S. Mohanavelu Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy - Thrombolysis in Myocardial Infarction 22) analysis J Am Coll Cardiol 52 2008 914 920
24. T.T. Tsai, B.K. Nallamothu, and D. Mukherjee Effect of statin use in patients with acute coronary syndromes and a serum low-density lipoprotein ≤ 80 mg/dl Am J Cardiol 96 2005 1491 1493
25. N.J. Leeper, R. Ardehali, and E.M. de Goma Statin use in patients with extremely low low-density lipoprotein levels is associated with improved survival Circulation 116 2007 613 618
26. B. Pitt, J. Loscalzo, and J. Ycas Lipid levels after acute coronary syndromes J Am Coll Cardiol 51 2008 1440 1445